Close Menu

Ohio State

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.

In Cell this week: DNA-based survey of marine virus genomes,  single-cell atlas of tumor proteomic profiles, and more.

Suit for Chair

According to Retraction Watch, Ohio State University's Carlo Croce is suing to be reinstated as department chair.

Ohio State University researchers found that a phosphorothioate-modified DNA-crRNA duplex completely blocked the function of Cas12a.

A brief recap of Genetics/Genomics news the week of Dec 14, 2018: AstraZeneca, NeoGenomics, Fluidigm, Luminex, Petco Foundation, and SQI Diagnostics

Croce Out as Chair

Retraction Watch reports Ohio State has pushed Carlo Croce to step down as department chair.

Mostly Dismissed

Retraction Watch reports that a judge dismissed most of the lawsuit Ohio State University's Carlo Croce brought against the New York Times.

Patients whose tumors had methylated MGMT promoters were more likely to survive than those that did not after combination treatment with radiotherapy and temozolomide.

Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.

Prospective panel sequencing on colorectal cancer patients picked up Lynch syndrome with sensitivity and specificity that met or exceeded gene-by-gene tests.

Pages

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.